Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Kyphon Inc. Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   63
ISBN Number   not applicable
Product Code   GMD692
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Kyphon Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Orthopedic Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Disc Disease Diagnosis and Therapies Product Category
      • 3.2.1 Overview
      • 3.2.2 Key Strategies
    • 3.3 Spinal Fracture Management and Repair Product Category
      • 3.3.1 Overview
      • 3.3.2 Key Strategies
    • 3.4 Spinal Motion Preservation Product Category
      • 3.4.1 Overview
      • 3.4.2 Key Strategies
    • 3.5 Major Products and Services
      • 3.5.1 Overview
  • 4 History
  • 5 Business Strategy
    • 5.1 Mission Statement
    • 5.2 Strategy
    • 5.3 Corporate Social Responsibility
      • 5.3.1 Overview
  • 6 Value Chain Analysis
    • 6.1 Manufacturing
      • 6.1.1 In House Manufacturing
      • 6.1.2 Outsourcing
    • 6.2 Product Development
      • 6.2.1 Regulatory Approvals
      • 6.2.2 Clinical Trials
      • 6.2.3 Research and Development
    • 6.3 Sales and Marketing
      • 6.3.1 Partnerships and Alliances
  • 7 Competitors
  • 8 Key Employees
  • 9 Key Employee Biographies
  • 10 Company Statement
  • 11 Locations And Subsidiaries
    • 11.1 Head Office
    • 11.2 Other Locations & Subsidiaries
  • 12 Recent Developments
    • 12.1 Financial Announcements
      • 12.1.1 Jul 27, 2007: Kyphon Reports Q2 2007 Results
      • 12.1.2 Apr 26, 2007: Kyphon Reports Q1 2007 Results
      • 12.1.3 Nov 01, 2006: Kyphon Reports Q3 2006 Results
      • 12.1.4 Jul 26, 2006: Kyphon Reports Q2 2006 Results
      • 12.1.5 Apr 27, 2006: Kyphon Reports Q1 2006 Results
    • 12.2 Corporate Communications
      • 12.2.1 Dec 11, 2007: Kyphon Delists From NASDAQ
      • 12.2.2 Apr 25, 2007: Kyphon Elects New Board Member
      • 12.2.3 Sep 18, 2006: Kyphon Appoints New CFO
      • 12.2.4 Jul 20, 2006: Kyphon Elects New Board Member
    • 12.3 Legal and Regulatory
      • 12.3.1 May 22, 2008: Medtronic To Pay $75 Million To Settle Medicare Fraud Allegations
    • 12.4 Product News
      • 12.4.1 Nov 21, 2005: Interspinous Process Decompression System (X Stop) for Symptoms of Lumbar Spine Stenosis
      • 12.4.2 Feb 05, 2003: Kyphon Launches Three New Products; Expands Product Portfolio Through The Introduction Of Next-Generation Technologies
  • 13 Kyphon Inc. Pipeline Products
    • 13.1 Kyphon Inc. Product Pipeline Analysis
      • 13.1.1 Kyphon Inc. Pipeline Products By Equipment Type
      • 13.1.2 Kyphon Inc. Pipeline Products By Development Stage
      • 13.1.3 Kyphon Inc. Pipeline Products By Therapy Area
      • 13.1.4 Kyphon Inc. Pipeline Products By Clinical Trials
    • 13.2 KyphX Xpander Inflatable Bone Tamp
      • 13.2.1 Product Description
      • 13.2.2 Product Status
      • 13.2.3 Clinical Trials
      • 13.2.4 Product Patent Details
      • 13.2.5 Product Patent Details
    • 13.3 KyphX Latitude Curette
      • 13.3.1 Product Description
      • 13.3.2 Product Status
      • 13.3.3 Clinical Trials
    • 13.4 KyphX Osteo Introducer System
      • 13.4.1 Product Description
      • 13.4.2 Product Status
    • 13.5 KyphX Bone Biopsy Device
      • 13.5.1 Product Description
      • 13.5.2 Product Status
      • 13.5.3 Product Patent Details
    • 13.6 KyphX Express Osteo Introducer System
      • 13.6.1 Product Description
      • 13.6.2 Product Status
    • 13.7 KyphX One-Step Osteo Introducer System
      • 13.7.1 Product Description
      • 13.7.2 Product Status
    • 13.8 KyphX Express Bone Biopsy Device
      • 13.8.1 Product Description
      • 13.8.2 Product Status
    • 13.9 KyphX Express Bone Filler Device
      • 13.9.1 Product Description
      • 13.9.2 Product Status
    • 13.10 KyphX Bone Filler Device
      • 13.10.1 Product Description
      • 13.10.2 Product Status
      • 13.10.3 Product Patent Details
    • 13.11 Aperius PercLID
      • 13.11.1 Product Description
      • 13.11.2 Product Status
    • 13.12 Discyphor catheter system (Next generation)
      • 13.12.1 Product Description
      • 13.12.2 Product Status
      • 13.12.3 Clinical Trials
    • 13.13 KyphX Xpander Inflation Syringe
      • 13.13.1 Product Description
      • 13.13.2 Product Status
    • 13.14 KyphX Elevate Inflatable Bone Tamp (IBT)
      • 13.14.1 Product Description
      • 13.14.2 Product Status
    • 13.15 KyphX Exact Inflatable Bone Tamp (IBT)
      • 13.15.1 Product Description
      • 13.15.2 Product Status
    • 13.16 KyphX HV-R (High-Viscosity Radiopaque) Bone Cement
      • 13.16.1 Product Description
      • 13.16.2 Product Status
    • 13.17 KyphX Express System
      • 13.17.1 Product Description
      • 13.17.2 Product Status
  • 14 Appendix
    • 14.1 Methodology
      • 14.1.1 Coverage
      • 14.1.2 Secondary Research
      • 14.1.3 Primary Research
      • 14.1.4 Expert Panel Validation
    • 14.2 Contact Us
    • 14.3 About Global Markets Direct
    • 14.4 Disclaimer
  • 1 List of Tables
    • Table 1: Kyphon Inc.,Key Facts, 2006
    • Table 2: Kyphon Inc., Key Employees, 2006
    • Table 3: Kyphon Inc., Other Locations
    • Table 4: Kyphon Inc., Subsidiaries
    • Table 5: Kyphon Inc. Pipeline Products by Equipment Type
    • Table 6: Kyphon Inc. Pipeline Products By Development Stage
    • Table 7: Kyphon Inc. Pipeline Products By Therapy Area
    • Table 8: Kyphon Inc. Pipeline Products By Clinical Trials
    • 1.2 List of Figures
    • Figure 1: Kyphon Inc., Value Chain Analysis
    • Figure 2: Kyphon Inc. Pipeline Products By Equipment Type
    • Figure 3: Kyphon Inc. Pipeline Products By Equipment Type
    • Figure 4: Kyphon Inc. Pipeline Products By Development Stage
    • Figure 5: Global Markets Direct Methodology